To invest, or not to invest? That is the question of new West End fund
Theatre lovers and investors are being given the opportunity to invest in London’s famed West End Theatre community, via a fund to be launched later this month.
The Theatre Fund will invest in a range of productions on stage in the theatre district of London, and it will offer shareholders other advantages including complimentary tickets to performances, and access to premium seats.
The fund, structured in the UK to qualify for the tax advantageous Enterprise Investment Scheme structure, will be advised by theatre producer Act Productions Limited.
Since 1994, Act Productions has produced shows for both the West End and Broadway.
Prominent shows it has produced include Death and the Maiden, Legally Blonde the Musical, Being Shakespeare, Flare Path starring Sienna Miller and ENRON.
Act’s managing director is Alan Davis. He has also worked at Warner Bros, and has been chairman of the Britannia Awards, and been on the first British Film Office executive committee in Hollywood.
While West End theatre attendance and revenues have shown growth over seven years, their fortunes can in part depend on the volume of Americans visiting London.
In 2009, despite a generally disadvantageous economic backdrop, the district’s theatres exceeded £500m in revenues for the first time, on attendance of a record 14.26 million viewers.
The previous year more than 14 million theatregoers attended a performance and although this was down 1% on 2009, the theatres still took in a record £512.3m, according to the Society of London Theatres.